BRIEF published on 07/17/2025 at 13:01, 1 year 1 month ago LAIQON AG Acquires €2.5bn in Assets, Target Price Increased LAIQON AG European Expansion Asset Acquisition Profitability Boost Investment Strength
BRIEF published on 07/17/2025 at 13:01, 1 year 1 month ago LAIQON AG acquiert 2,5 milliards d'euros d'actifs, objectif de prix relevé Expansion Européenne Augmentation De La Rentabilité LAIQON AG Acquisition D'actifs Force D'investissement
PRESS RELEASE published on 07/17/2025 at 12:56, 1 year 1 month ago Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates buy recommendation for LAIQON AG following acquisition of €2.5bn in assets from MainFirst Affiliated Fund Managers, increasing price target to €10.60 Acquisition Asset Management First Berlin Equity Research Price Target LAIQON AG
BRIEF published on 04/28/2025 at 11:45, 1 year 4 months ago LAIQON AG Receives Updated Buy Rating from First Berlin Equity Research Financial Results Buy Recommendation Target Price Assets Under Management LAIQON AG
BRIEF published on 04/28/2025 at 11:45, 1 year 4 months ago LAIQON AG reçoit une nouvelle note d'achat de First Berlin Equity Research Résultats Financiers Recommandation D'achat LAIQON AG Actifs Sous Gestion Prix Cible
PRESS RELEASE published on 04/28/2025 at 11:40, 1 year 4 months ago Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research reaffirms Buy rating for LAIQON AG with an updated price target of €9.00 following the publication of FY 2024 financial results Financial Results First Berlin Equity Research BUY Rating Price Target LAIQON AG
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago LAIQON AG: Positive Growth and Financial Outlook for FY'25 Investment Recommendation Assets Under Management Financial Growth LAIQON AG Cost Management
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago LAIQON AG : Croissance positive et perspectives financières pour l'exercice 2025 Croissance Financière LAIQON AG Actifs Sous Gestion Gestion Des Coûts Recommandation D'investissement
PRESS RELEASE published on 04/15/2025 at 09:00, 1 year 4 months ago Original-Research: LAIQON AG (von NuWays AG): BUY LAIQON AG, previously NuWays AG, upgraded to BUY with a target price of EUR 7.40 for scaling AuM and improved cost mix. FY'24 review highlights strong sales and EBITDA growth Buy Recommendation LAIQON AG Scaling AuM Cost Mix FY'24 Review
BRIEF published on 03/13/2025 at 09:07, 1 year 5 months ago LAIQON AG Projects Strong Growth Amid Strategic Transformations Wealth Management Financial Growth LAIQON AG 2025 Outlook Asset Divestment
Published on 08/31/2026 at 02:05, 5 hours 34 minutes ago Tunkillia Infill Drilling Confirms New High-grade Mineralisation Within Shallow Zone of Existing High-value 'Starter Pit' Outlines
Published on 08/29/2026 at 05:15, 2 days 2 hours ago Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 2 days 4 hours ago BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 2 days 6 hours ago Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 2 days 6 hours ago Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/31/2026 at 07:00, 38 minutes ago PolyPeptide Group: Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG
Published on 08/31/2026 at 06:30, 1 hour 9 minutes ago HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management
Published on 08/31/2026 at 03:00, 4 hours 39 minutes ago Style3D Advances Fashion AI from Content Generation to Connected Product Workflows
Published on 08/29/2026 at 04:05, 2 days 3 hours ago INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 2 days 10 hours ago Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/31/2026 at 07:00, 39 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Published on 08/31/2026 at 07:00, 39 minutes ago Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
